NASDAQ : COO
The Cooper Companies, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 60.34 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.47B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 11.32B |
| Enterprise Value | 13.97B |
Dates
| Measure | Value |
|---|
| Earnings Date | Dec 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 190.16M |
| Shares Outstanding | 190.16M |
| Shares Change (YoY) | -2.33% |
| Shares Change (QoQ) | -0.82% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 110.71% |
| Float | 188.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.50 |
| Forward PE | 13.07 |
| PS Ratio | 2.67 |
| Forward PS | 2.60 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | 16.70 |
| P/OCF Ratio | 10.96 |
| PEG Ratio | 1.92 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 24.50 |
| EV / Sales | 3.30 |
| EV / EBITDA | 14.99 |
| EV / EBIT | 25.49 |
| EV / FCF | 20.61 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.22 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 2.83 |
| Debt / FCF | 4.13 |
| Interest Coverage | 6.14 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 6.84% |
| Return on Assets (ROA) | 2.73% |
| Return on Invested Capital (ROIC) | 5.03% |
| Return on Capital Employed (ROCE) | 5.07% |
| Weighted Average Cost of Capital (WACC) | 7.54% |
| Revenue Per Employee | $282,460 |
| Profits Per Employee | $38,020 |
| Employee Count | 15,000 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 1.61 |
Taxes
| Measure | Value |
|---|
| Income Tax | -107.90M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -14.42% |
| 50-Day Moving Average | 60.33 |
| 200-Day Moving Average | 68.90 |
| Relative Strength Index (RSI) | 52.52 |
| Average Volume (20 Days) | 3,386,976 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.09M |
| Short Previous Month | 8.33M |
| Short % of Shares Out | 4.78% |
| Short % of Float | 4.81% |
| Short Ratio (days to cover) | 2.03 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 4.24B |
| Gross Profit | 2.79B |
| Operating Income | 548.00M |
| Pretax Income | 462.40M |
| Net Income | 570.30M |
| EBITDA | 932.00M |
| EBIT | 548.00M |
| Earnings Per Share (EPS) | $2.90 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 154.70M |
| Total Debt | 2.80B |
| Net Cash | -2.65B |
| Net Cash Per Share | -$13.92 |
| Equity (Book Value) | 8.33B |
| Book Value Per Share | 43.81 |
| Working Capital | 414.90M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.03B |
| Capital Expenditures | -355.30M |
| Depreciation & Amortization | 384.00M |
| Net Borrowing | 66.20M |
| Free Cash Flow | 678.00M |
| FCF Per Share | $3.57 |
Margins
| Measure | Value |
|---|
| Gross Margin | 65.93% |
| Operating Margin | 12.93% |
| Pretax Margin | 10.91% |
| Profit Margin | 13.46% |
| EBITDA Margin | 22.00% |
| EBIT Margin | 12.93% |
| FCF Margin | 16.00% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.33% |
| Shareholder Yield | 2.33% |
| Earnings Yield | 4.88% |
| FCF Yield | 5.99% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $65.80 |
| Price Target Difference | 10.50% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 4.12% |
| EPS Growth Forecast (3Y) | 7.30% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 20, 2024 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.38 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |